Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents

详细信息

下载全文

推荐本文 |

• 作者：D. D. V. Brito (13)
  A. P. Fernandes (1)
  K. B. Gomes (1) karina@coltec.ufmg.br
  F. F. Coelho (1)
  N. G. Cruz (1)
  A. P. Sabino (1)
  J. E. Cardoso (1)
  P. P. Figueiredo-Filho (2)
  R. Diamante (2)
  C. R. Norton (2)
  M. O. Sousa (1)
• 关键词：APOA5 &#8211 ; APOE &#8211 ; Dyslipidemia &#8211 ; Children &#8211 ; Adolescents
• 刊名：Molecular Biology Reports
• 出版时间：October 2011
• 出版年：2011
• 期刊代码：39_03014851
• 类别：cp
• 卷：38
• 期：7
• 页码：4381-4388
• 数据来源：sp

摘要

Apolipoprotein A5 (APOA5) and apolipoprotein E (APOE) play important roles in the metabolism of cholesterol and triglycerides. The aim of this study was to determine the allelic and genotypic distributions of the APOA5-1131T>C (rs 662799) and the APOE HhaI polymorphisms and to identify the association of both individual and combined APOA5–APOE genetic variants and the risk for dyslipidemia in children and adolescents. We genotyped 53 dyslipidemic and 77 normolipidemic individuals. The total cholesterol, triglycerides and HDL cholesterol were determined enzymatically. For APOA5 polymorphism, the presence of the allele C confers an individual risk for dyslipidemia (OR = 2.38, 95%CI = 1.15–4.89; P = 0.018). No significant differences were observed for lipid parameters among the APOA5 groups, except for a higher value of HDLc (P = 0.024) in C-carriers. The allelic and genotypic frequencies of APOE polymorphism were similar between groups and did not increase the susceptibility for dyslipidemia. None of the combined APOA5–APOE polymorphisms increased risk for dyslipidemia. We demonstrated an association between APOA5-1131T>C polymorphism and dyslipidemia in children and adolescents. This finding may be useful to guide new studies with genetic markers down a path toward a better characterization of the genetic risk factors for dyslipidemia and atherosclerotic diseases.